FDA — authorised 4 May 1962
- Application: NDA013056
- Marketing authorisation holder: ABBOTT
- Local brand name: PENTHRANE
- Indication: LIQUID — INHALATION
- Status: approved
🇺🇸 Metofane in United States
FDA authorised Metofane on 4 May 1962
Marketing authorisations
FDA
- Marketing authorisation holder: ABBOTT
- Status: approved
Metofane in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Metofane approved in United States?
Yes. FDA authorised it on 4 May 1962; FDA has authorised it.
Who is the marketing authorisation holder for Metofane in United States?
ABBOTT holds the US marketing authorisation.